Suppression of nuclear factor-κB and stimulation of inhibitor κB by troglitazone: Evidence for an antiinflammatory effect and a potential antiatherosclerotic effect in the obese

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 3, 2001, Pages 1306-1312

  Ghanim, Husam ^a   Garg, Rajesh ^a   Aljada, Ahmad ^a   Mohanty, Priya ^a   Kumbkarni, Yuvraj ^a   Assian, Ezzat ^a   Hamouda, Wael ^a   Dandona, Paresh ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b Diabetes Endocrinology Center of Western New York   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TROGLITAZONE;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; DRUG EFFECT; DRUG USE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL;

ADULT; ANTI-INFLAMMATORY AGENTS; ARTERIOSCLEROSIS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CELL NUCLEUS; CHEMOKINE CCL2; CHROMANS; FEMALE; HUMANS; I-KAPPA B PROTEINS; INSULIN; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; NADPH OXIDASE; NF-KAPPA B; OBESITY; PHOSPHOPROTEINS; PLASMINOGEN ACTIVATOR INHIBITOR 1; REACTIVE OXYGEN SPECIES; THIAZOLES; THIAZOLIDINEDIONES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035045084     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.3.1306     Document Type: Article

References (43)

1. Thiazolidinediones in the treatment of insulin resistance and type II diabetes
2. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
3. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
4. Atherosclerosis - An inflammatory disease
5. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
6. Peroxisome proliferator-activated receptor α in metabolic disease, inflammation, atherosclerosis and aging
7. A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response
8. Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes
9. Nuclear factor-κB: A pivotal transcription factor in chronic inflammatory diseases
10. Molecular control of immune/inflammatory responses: Interactions between nuclear factor-κB and steroid receptor-signaling pathways
11. Increased IκB expression and diminished nuclear NF-κB in human mononuclear cells following hydrocortisone injection
12. Effect of hydrocortisone on oxygen free radical generation by mononuclear cells
13. Isolation of a complex of respiratory burst oxidase components from resting neutrophil cytosol
14. Neutrophil nicotinamide adenine dinucleotide phosphate oxidase assembly. Translocation of p47-phox and p67-phox requires interaction between p47-phox and cytochrome b558
15. In vitro knockout of human p47phox blocks superoxide anion production and LDL oxidation by activated human monocytes
16. Carvedilol inhibits reactive oxygen species generation by leukocytes and oxidative damage to amino acids
17. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells
18. A rapid, specific assay for superoxide release from phagocytes in small volumes of whole blood
19. The inhibition by diphenyleneiodonium and its analogues of superoxide generation by macrophages
20. Role of transcriptional activation of I κ B α in mediation of immunosuppression by glucocorticoids
21. Immunosuppression by glucocorticoids: Inhibition of NF-κB activity through induction of I κ B synthesis
22. Inhibition of NF-κ B by sodium salicylate and aspirin
23. Effects of troglitazone on frequency of coronary vasospastic-induced angina pectoris in patients with diabetes mellitus
24. Troglitazone reduces reactive oxygen species generation by leukocytes and lipid peroxidation and improves flow-mediated vasodilatation in obese subjects
25. C-reactive protein binding to FcyRIIa on human monocytes and neutrophils is allele-specific
26. Cytokine-activated human endothelial monolayers support enhanced neutrophil transmigration via a mechanism involving both endothelial-leukocyte adhesion molecule-1 and intercellular adhesion molecule-1
27. Intercellular adhesion molecule-1
28. Enhancement of monocyte q migration by granulocyte-macrophage colony-stimulating factor: Requirement for chemoattractant and CD11a/CD18 mechanisms
29. Increase in plasma interleukin-10 following hydrocortisone injection
30. Properties and functions of interleukin-10
31. Biological properties of interleukin 10
32. Macrophages in human atheroma contain PPARγ: Differentiation-dependent peroxisomal proliferator-activated receptor γ (PPARγ) expression and reduction of MMP-9 activity through PPARγ activation in mononuclear phagocytes in vitro
33. Inhibition of IKKβ reverses "insulin resistance" in cultured cells
34. Salicylate inhibition of IKKβ (IkB kinase) reverses insulin resistance in Zucker (fa/fa) rats
35. α-tocopherol enrichment of monocytes decreases agonist-induced adhesion to human endothelial cells
36. Effect of vitamin E on oxygen free radical generation by leucocytes and protein oxidative damage products ortho- and meta-tyrosine
37. A dipose expression of tumor necrosis factor-α: Direct role in obesity-linked insulin resistance
38. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance
39. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase
40. Tumor necrosis factor-α in sera of obese patients: Fall with weight loss
41. The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation and protein carbonylation
42. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ)
43. Antiinflammatory actions of 15-deoxy-delta 12,14-prostaglandin J2 and troglitazone: Evidence for heat shock-dependent and -independent inhibition of cytokine-induced inducible nitric oxide synthase expression